Association of plasma biomarkers, p‐tau181, glial fibrillary acidic protein, and neurofilament light, with intermediate and long‐term clinical Alzheimer's disease risk: Results from a prospective cohort followed over 17 years-Reference-Cited by-同舟云学术

Association of plasma biomarkers, p‐tau181, glial fibrillary acidic protein, and neurofilament light, with intermediate and long‐term clinical Alzheimer's disease risk: Results from a prospective cohort followed over 17 years

Published:2022-03-02 Issue:1 Volume:19 Page:25-35
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Stocker Hannah¹²,Beyer Léon³⁴,Perna Laura⁵,Rujescu Dan⁶,Holleczek Bernd⁷,Beyreuther Konrad¹,Stockmann Julia³⁴,Schöttker Ben¹²,Gerwert Klaus³⁴,Brenner Hermann¹²

Affiliation:

1. Network Aging Research Heidelberg University Heidelberg Germany

2. Division of Clinical Epidemiology and Aging Research German Cancer Research Center Heidelberg Germany

3. Center for Protein Diagnostics (ProDi) Ruhr‐University Bochum Bochum Germany

4. Faculty of Biology and Biotechnology Department of Biophysics Ruhr‐University Bochum Bochum Germany

5. Department of Translational Research in Psychiatry – Max Planck Institute of Psychiatry Munich Germany

6. Department of Psychiatry University of Vienna Vienna Austria

7. Saarland Cancer Registry Saarbrücken Germany

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12614

Reference39 articles.

1. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

2. Amyloid blood biomarker detects Alzheimer's disease

3. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

4. Alzheimer’s disease biomarker roadmap 2020: Fluid biomarkers

5. Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CSF and blood glial fibrillary acidic protein for the diagnosis of Alzheimer's disease: A systematic review and meta-analysis;Ageing Research Reviews;2024-11

2. Differential neuropsychiatric associations of plasma biomarkers in older adults with major depression and subjective cognitive decline;Translational Psychiatry;2024-08-16

3. Astrocyte reactivity is associated with tau tangle load and cortical thinning in Alzheimer’s disease;Molecular Neurodegeneration;2024-07-30

4. Tracking neuroinflammatory biomarkers in Alzheimer’s disease: a strategy for individualized therapeutic approaches?;Journal of Neuroinflammation;2024-07-30

5. Clinical Application of Blood Biomarkers in Neurodegenerative Diseases—Present and Future Perspectives;International Journal of Molecular Sciences;2024-07-25